Access to mental health services wasn’t great before the pandemic. Then two things happened: the need for mental health services increased. But so has access to telemedicine providers of mental health support.
The Drug Enforcement Administration (DEA) enabled flexibilities regarding the prescription of controlled medications. In 2020, the Food and Drug Administration announced a pandemic enforcement policy allowing mental health app developers to release certain treatment products without seeking authorization from the agency.
Cerebral is a US online therapy provider, founded in 2019. In 2021, the company raised close to half a billion dollars and was valued at 4.8 billions USD. Even Olympic gymnast Simone Biles, who withdraw from the Olympic games in Tokyo in 2020 due to personal mental health struggles, and became a public advocate for a new attitude and public perception of how we approach mental health, struck a partnership with Cerebral, joining as an investor and its chief impact officer.
But then in 2022, things started to shift in the opposite direction, due to allegations of unsafe prescribing practices. The Wall Street Journal, Insider, and other media publications investigated and reported about these through the accounts of patients and former employees, and the Department of Justice launched an investigation about "possible violations" of the Controlled Substances Act. Eventually, in 2022, the company dropped prescribing of Controlled Substance Prescriptions entirely.
Today Cerebral is moving forward and is betting on quality mental health provision, with high hopes around enhancements that could be achieved with the help of AI. In today’s discussion, you will hear from Cerebral’s CEO David Mou, talk about:
Website: www.facesofdigitalhealth.com
Newsletter: https://fodh.substack.com/
Read more on mental health:
https://fodh.substack.com/p/mentalhealth
HIMSS Europe 2024: EHDS, future of interoperability, next steps in AI, and where patient journey fits in?
Can We Harmonize Medication Management Across Europe?
Learning From pan-Canadian Health Data Strategy - What's Next to EHDS? (Eric Sutherland)
Switzerland, AI and Liquid Biopsies
Healthtech in the GCC Countries: Focus on Infrastructure and Export Capabilities
DTx in 2024: Where Are We With Business and Reimbursement Models? (Andy Molnar)
What Factors Should You Take into Account when Designing ePROs - Electronic Patient Reported Outcomes Solutions?
DTx in Belgium: It's Time to Embed Digital Therapeutics in Clinical Pathways
In the Rapid Advancements in Oncology Treatments, How Can Healthcare IT Support Clinicians? (Elekta)
How Do Pharma and Digital Health Converge in 2024? (Amir Lahav)
Experience Economy: How To Create Healthcare Events the HLTH Way (Richard Scarfo)
Gender Impact On Health Is Huge - Women's Health Research Needs More Investments
How Can We Reduce Unnecessary Lab Testing?
Innovation at Charité, The Problems With DiGAs and the German Market (Dorothée Marie-Louise Döpfer)
The Rise of Non-Traditional Prescribers in the US and the role of ePrescribing
"Women's Health Space Is Not Doing Much Better Today Than 10 years Ago" (Marija Butkovic)
Why Human Connection Is Medicine, and How is Tech an Enabler
US and Europe: A Snapshot of Healthcare Innovation (Jody Tropeano, Henry Stoneley, HLTH)
How To Get Patient Feedback That Is Actionable
Upside Down: How AI Changed Healthcare in 2023
Create your
podcast in
minutes
It is Free
Insight Story: Tech Trends Unpacked
Zero-Shot
Fast Forward by Tomorrow Unlocked: Tech past, tech future
The Unbelivable Truth - Series 1 - 26 including specials and pilot
Lex Fridman Podcast